IP Verse

Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production - EP3581650B1

PatentPatent Analysis

EP3581650

UNIQURE BIOPHARMA
Application Number
EP19174517A
Filing Date
Sep 15, 2009
Status
Granted And Under Opposition
Nov 25, 2022
Grant Date
Dec 28, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4032979B1
EP2337849B1

Bibliography

The patent EP3581650B1 was granted to Uniqure Biopharma on Dec 28, 2022 following the initial filing on Sep 15, 2009 under the application number EP19174517A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERSep 27, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents